List of Excipients in API amlodipine besylate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing amlodipine besylate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | NORVASC | amlodipine besylate | 0069-1520 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | |
| PFIZER LABORATORIES DIV PFIZER INC | NORVASC | amlodipine besylate | 0069-1520 | CELLULOSE, MICROCRYSTALLINE | |
| PFIZER LABORATORIES DIV PFIZER INC | NORVASC | amlodipine besylate | 0069-1520 | MAGNESIUM STEARATE | |
| PFIZER LABORATORIES DIV PFIZER INC | NORVASC | amlodipine besylate | 0069-1520 | SODIUM STARCH GLYCOLATE TYPE A POTATO | |
| Rebel Distributors Corp | NORVASC | amlodipine besylate | 21695-151 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | |
| Rebel Distributors Corp | NORVASC | amlodipine besylate | 21695-151 | CELLULOSE, MICROCRYSTALLINE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing amlodipine besylate
Detailed excipient profiles for amlodipine besylate
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
amlodipine besylate drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
amlodipine besylate drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Excipient focus: ANHYDROUS LACTOSE
amlodipine besylate drug variants containing ANHYDROUS LACTOSE
amlodipine besylate drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BUTYLATED HYDROXYTOLUENE
amlodipine besylate drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | amlodipine besylate | 53808-0686 |
| >Company | >Ingredient | >NDC |
amlodipine besylate drug variants not containing BUTYLATED HYDROXYTOLUENE
Excipient focus: CALCIUM CARBONATE
amlodipine besylate drug variants containing CALCIUM CARBONATE
amlodipine besylate drug variants not containing CALCIUM CARBONATE
Excipient focus: CALCIUM PHOSPHATE
amlodipine besylate drug variants containing CALCIUM PHOSPHATE
amlodipine besylate drug variants not containing CALCIUM PHOSPHATE
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
amlodipine besylate drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
amlodipine besylate drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: CELLULOSE, MICROCRYSTALLINE
amlodipine besylate drug variants containing CELLULOSE, MICROCRYSTALLINE
amlodipine besylate drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COLLOIDAL SILICON DIOXIDE
amlodipine besylate drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | amlodipine besylate and benazepril hydrochloride | 54868-6297 |
| Dr Reddy's Laboratories | amlodipine besylate | 55111-269 |
| WOCKHARDT LIMITED | amlodipine besylate | 55648-421 |
| >Company | >Ingredient | >NDC |
amlodipine besylate drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSCARMELLOSE SODIUM
amlodipine besylate drug variants containing CROSCARMELLOSE SODIUM
amlodipine besylate drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
amlodipine besylate drug variants containing CROSPOVIDONE
amlodipine besylate drug variants not containing CROSPOVIDONE
Excipient focus: D&C RED NO. 28
amlodipine besylate drug variants containing D&C RED NO. 28
amlodipine besylate drug variants not containing D&C RED NO. 28
Excipient focus: D&C YELLOW NO. 10
amlodipine besylate drug variants containing D&C YELLOW NO. 10
amlodipine besylate drug variants not containing D&C YELLOW NO. 10
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
amlodipine besylate drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
amlodipine besylate drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Excipient focus: FD&C BLUE NO. 1
amlodipine besylate drug variants containing FD&C BLUE NO. 1
amlodipine besylate drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
amlodipine besylate drug variants containing FD&C BLUE NO. 2
amlodipine besylate drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C GREEN NO. 3
amlodipine besylate drug variants containing FD&C GREEN NO. 3
amlodipine besylate drug variants not containing FD&C GREEN NO. 3
Excipient focus: FD&C RED NO. 40
amlodipine besylate drug variants containing FD&C RED NO. 40
amlodipine besylate drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 5
amlodipine besylate drug variants containing FD&C YELLOW NO. 5
amlodipine besylate drug variants not containing FD&C YELLOW NO. 5
Excipient focus: FD&C YELLOW NO. 6
amlodipine besylate drug variants containing FD&C YELLOW NO. 6
amlodipine besylate drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
amlodipine besylate drug variants containing FERRIC OXIDE RED
amlodipine besylate drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
amlodipine besylate drug variants containing FERRIC OXIDE YELLOW
amlodipine besylate drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
amlodipine besylate drug variants containing FERROSOFERRIC OXIDE
amlodipine besylate drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
amlodipine besylate drug variants containing GELATIN
amlodipine besylate drug variants not containing GELATIN
Excipient focus: HYDROGENATED CASTOR OIL
amlodipine besylate drug variants containing HYDROGENATED CASTOR OIL
amlodipine besylate drug variants not containing HYDROGENATED CASTOR OIL
Excipient focus: HYDROGENATED SOYBEAN LECITHIN
amlodipine besylate drug variants containing HYDROGENATED SOYBEAN LECITHIN
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | amlodipine besylate and atorvastatin calcium | 43598-323 |
| >Company | >Ingredient | >NDC |
amlodipine besylate drug variants not containing HYDROGENATED SOYBEAN LECITHIN
Excipient focus: HYDROXYPROPYL CELLULOSE
amlodipine besylate drug variants containing HYDROXYPROPYL CELLULOSE
amlodipine besylate drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
amlodipine besylate drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | amlodipine besylate and benazepril hydrochloride | 0078-0405 |
| A-S Medication Solutions | amlodipine besylate and valsartan | 50090-2471 |
| >Company | >Ingredient | >NDC |
amlodipine besylate drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSES
amlodipine besylate drug variants containing HYPROMELLOSES
amlodipine besylate drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE
amlodipine besylate drug variants containing LACTOSE
amlodipine besylate drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
amlodipine besylate drug variants containing LACTOSE MONOHYDRATE
amlodipine besylate drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
amlodipine besylate drug variants containing MAGNESIUM STEARATE
amlodipine besylate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
amlodipine besylate drug variants containing MANNITOL
amlodipine besylate drug variants not containing MANNITOL
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
amlodipine besylate drug variants containing MICROCRYSTALLINE CELLULOSE 102
amlodipine besylate drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: POLYETHYLENE GLYCOL
amlodipine besylate drug variants containing POLYETHYLENE GLYCOL
amlodipine besylate drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3000
amlodipine besylate drug variants containing POLYETHYLENE GLYCOL 3000
amlodipine besylate drug variants not containing POLYETHYLENE GLYCOL 3000
Excipient focus: POLYETHYLENE GLYCOL 3350
amlodipine besylate drug variants containing POLYETHYLENE GLYCOL 3350
amlodipine besylate drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
amlodipine besylate drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | amlodipine besylate and benazepril hydrochloride | 49884-929 |
| Bryant Ranch Prepack | amlodipine besylate and benazepril hydrochloride | 63629-4878 |
| >Company | >Ingredient | >NDC |
amlodipine besylate drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 4000
amlodipine besylate drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | amlodipine besylate and olmesartan medoxomil | 16729-392 |
| >Company | >Ingredient | >NDC |
amlodipine besylate drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYSORBATE 80
amlodipine besylate drug variants containing POLYSORBATE 80
amlodipine besylate drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
amlodipine besylate drug variants containing POLYVINYL ALCOHOL
amlodipine besylate drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POTASSIUM HYDROXIDE
amlodipine besylate drug variants containing POTASSIUM HYDROXIDE
amlodipine besylate drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POVIDONE
amlodipine besylate drug variants containing POVIDONE
amlodipine besylate drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
amlodipine besylate drug variants containing POVIDONE K30
amlodipine besylate drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
amlodipine besylate drug variants containing PROPYLENE GLYCOL
amlodipine besylate drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
amlodipine besylate drug variants containing SHELLAC
amlodipine besylate drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
amlodipine besylate drug variants containing SILICON DIOXIDE
amlodipine besylate drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BICARBONATE
amlodipine besylate drug variants containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | amlodipine besylate and atorvastatin calcium | 43598-323 |
| >Company | >Ingredient | >NDC |
amlodipine besylate drug variants not containing SODIUM BICARBONATE
Excipient focus: SODIUM LAURYL SULFATE
amlodipine besylate drug variants containing SODIUM LAURYL SULFATE
amlodipine besylate drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
amlodipine besylate drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
amlodipine besylate drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SODIUM STARCH GLYCOLATE TYPE B POTATO
amlodipine besylate drug variants containing SODIUM STARCH GLYCOLATE TYPE B POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | amlodipine besylate | 0143-9959 |
| >Company | >Ingredient | >NDC |
amlodipine besylate drug variants not containing SODIUM STARCH GLYCOLATE TYPE B POTATO
Excipient focus: STARCH, CORN
amlodipine besylate drug variants containing STARCH, CORN
amlodipine besylate drug variants not containing STARCH, CORN
Excipient focus: STARCH, POTATO
amlodipine besylate drug variants containing STARCH, POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | amlodipine besylate and olmesartran medoxomil | 46708-212 |
| Alembic Pharmaceuticals Inc | amlodipine besylate and olmesartran medoxomil | 62332-212 |
| >Company | >Ingredient | >NDC |
amlodipine besylate drug variants not containing STARCH, POTATO
Excipient focus: STEARIC ACID
amlodipine besylate drug variants containing STEARIC ACID
amlodipine besylate drug variants not containing STEARIC ACID
Excipient focus: TALC
amlodipine besylate drug variants containing TALC
amlodipine besylate drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
amlodipine besylate drug variants containing TITANIUM DIOXIDE
amlodipine besylate drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIETHYL CITRATE
amlodipine besylate drug variants containing TRIETHYL CITRATE
amlodipine besylate drug variants not containing TRIETHYL CITRATE
Excipient focus: WATER
amlodipine besylate drug variants containing WATER
amlodipine besylate drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
